Eiger Biopharmaceuticals (EIGR) has released an update to notify the public and investors about its officers.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Eldon Mayer III has resigned as the Chief Commercial Officer of Eiger BioPharmaceuticals, Inc., with his resignation set to take effect on February 2, 2024. He notified the company of his decision on January 18, 2024.
For further insights into EIGR corporate activity, check out TipRanks’ Insiders Trading Activity page.
